clinical trials

Ex-Gilead execs bag $80M to trial drug licensed from Merck KGaA
Ex-Gilead execs bag $80M to trial drug licensed from Merck KGaA
Fierce Biotech
Vera Therapeutics
Merck KGaA
clinical trials
kidney disease
atacicept
Gilead Sciences
Flag link:
Small biotech launches human trials of a potential ‘backstop’ for Covid-19 vaccines
Small biotech launches human trials of a potential ‘backstop’ for Covid-19 vaccines
Stat
Gritsone Oncology
COVID-19
vaccines
clinical trials
Flag link:
Biohaven Provides Update On Phase 2/3 Trial And Alzheimer's Disease Program
Biohaven Provides Update On Phase 2/3 Trial And Alzheimer's Disease Program
BioSpace
Biohaven
Alzheimer's disease
clinical trials
troriluzole
Flag link:
10 key clinical trials to watch in the first half of 2021
10 key clinical trials to watch in the first half of 2021
BioPharma Dive
clinical trials
Novavax
AstraZeneca
JNJ
vaccines
COVID-19
Biomarin
Amgen
Merck
Pfizer
Roche
SAGE Therapeutics
Biogen
Vertex Pharmaceuticals
Flag link:
J&J single-shot COVID-19 vaccine shows early promise
J&J single-shot COVID-19 vaccine shows early promise
Pharmaforum
JNJ
COVID-19
vaccines
clinical trials
Flag link:
Moderna to Test Coronavirus Vaccine Booster Shot in New Clinical Trial
Moderna to Test Coronavirus Vaccine Booster Shot in New Clinical Trial
Motley Fool
Moderna Therapeutics
vaccines
clinical trials
mRNA-1273
COVID-19
Flag link:
IO Biotech raises $155M to trial IDO and PD-L1 cancer vaccines
IO Biotech raises $155M to trial IDO and PD-L1 cancer vaccines
Fierce Biotech
IO Biotech
IDO
PD-L1
vaccines
cancer vaccines
clinical trials
Flag link:
Could Lilly’s donanemab readout in Alzheimer’s boost Biogen’s prospects?
Could Lilly’s donanemab readout in Alzheimer’s boost Biogen’s prospects?
Pharmaforum
Eli Lilly
Alzheimer's disease
clinical trials
donanemab
Flag link:
5 questions facing the FDA in 2021
5 questions facing the FDA in 2021
BioPharma Dive
FDA
Joe Biden
COVID-19
pandemic
PDUFA VII
clinical trials
Flag link:
Knopp’s oral asthma drug hits primary endpoint in phase 2
Knopp’s oral asthma drug hits primary endpoint in phase 2
Fierce Biotech
Knopp Biosciences
clinical trials
dexpramipexole
eosinophilic asthma
Flag link:
Data fuel debate over whether J&J’s one-dose Covid vaccine will measure up
Data fuel debate over whether J&J’s one-dose Covid vaccine will measure up
Stat
JNJ
vaccines
COVID-19
clinical trials
Flag link:
Celltrion's COVID-19 antibody improves outcomes in phase 2
Celltrion's COVID-19 antibody improves outcomes in phase 2
Fierce Biotech
Celltrion
COVID-19
antibodies
clinical trials
Flag link:
Adastra Pharma’s Novel Glioma Therapy Achieves Positive Phase Ib Outcomes
Adastra Pharma’s Novel Glioma Therapy Achieves Positive Phase Ib Outcomes
BioSpace
Adastra
clinical trials
glioblastoma
Flag link:
‘No going back’ for clinical trials after COVID
‘No going back’ for clinical trials after COVID
Pharmaforum
clinical trials
virtual clinical trials
pandemic
COVID-19
Flag link:
Gilead & Vir Announce Collaboration To Find Cure For Hepatitis B Virus
Gilead & Vir Announce Collaboration To Find Cure For Hepatitis B Virus
NASDAQ
Gilead Sciences
Vir Biotechnology
hepatitis B
clinical trials
Flag link:
JPM: 'Very soon,' says Johnson & Johnson CEO as world waits for its COVID-19 vaccine data
JPM: 'Very soon,' says Johnson & Johnson CEO as world waits for its COVID-19 vaccine data
Fierce Pharma
JNJ
JPMHC 2021
vaccines
COVID-19
clinical trials
Flag link:
Lilly rockets up on mixed Alzheimer's results
Lilly rockets up on mixed Alzheimer's results
BioPharma Dive
Eli Lilly
Alzheimer's disease
clinical trials
donanemab
Flag link:
BioMarin tries to get hemophilia gene therapy back on track with positive data
BioMarin tries to get hemophilia gene therapy back on track with positive data
BioPharma Dive
Biomarin
hemophilia A
gene therapy
clinical trials
Roctavian
Flag link:
Hot on the heels of a positive PhIII, Immunocore hauls in $175M as it hunts its first TCR OK
Hot on the heels of a positive PhIII, Immunocore hauls in $175M as it hunts its first TCR OK
Endpoints
Immunocore
clinical trials
tebentafusp
uveal melanoma
Flag link:
Is Johnson & Johnson an Underdog in the Coronavirus Vaccine Race?
Is Johnson & Johnson an Underdog in the Coronavirus Vaccine Race?
Motley Fool
JNJ
vaccines
COVID-19
Ad26.COV2-S
clinical trials
Flag link:

Pages